Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome

ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)


Volume 20, 42 Issues, 2014


Download PDF Flyer




Current Pharmaceutical Design

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 62nd of 254 in Pharmacology & Pharmacy

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.288
5 - Year: 3.555

Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome

Author(s): Konstantinos Tziomalos, Vasilios G. Athyros and Asterios Karagiannis

Affiliation: First Propedeutic Department of Internal Medicine, AHEPA Hospital 1 Stilponos Kyriakidi street, 546 36, Thessaloniki, Greece

Abstract

Arterial stiffness is independently associated with increased cardiovascular risk in patients with cardiovascular risk factors and in the general population. Metabolic syndrome (MetS) is frequently characterized by increased arterial stiffness since all components of MetS are implicated in the pathogenesis of arterial stiffness. We review the management of arterial stiffness in patients with MetS. Several small, short-term studies showed that lifestyle changes, antidiabetic, antihypertensive and lipid-lowering agents improve arterial elasticity. However, differences appear to exist between different classes of agents, with statins and inhibitors of the renin-angiotensin-aldosterone system having the more favorable effects on arterial stiffness. A multifactorial approach appears to be the optimal management of increased arterial stiffness in patients with MetS


Purchase Online Rights and Permissions

  
  



Article Details

Volume: 20
First Page: 1
Page Count: 1
DOI: 10.2174/1381612820666140417101523
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science